Autolus Therapeutics (AUTL) Change in Inventory (2024 - 2025)
Autolus Therapeutics posted quarterly Change in Inventory of $10.1 million for Q4 2025, up 139.06% year-on-year from $4.2 million in Q4 2024, and up 17.53% on a QoQ basis from $8.6 million in Q3 2025.
Autolus Therapeutics (AUTL) has 2 years of Change in Inventory data on file, last reported at $10.1 million in Q4 2025.
- For the quarter ending Q4 2025, Change in Inventory rose 139.06% year-over-year to $10.1 million; the trailing twelve-month figure through Dec 2025 stood at $40.2 million (up 851.76% YoY), and the FY2025 full-year result was $40.2 million, up 851.76% from the prior year.
- Change in Inventory for Q4 2025 stood at $10.1 million, up from $8.6 million in the prior quarter.
- Across five years, Change in Inventory topped out at $11.4 million in Q2 2025 and bottomed at $4.2 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 665.00 |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 97.70 Mn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | -26.60 Mn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 3.32 Mn |
| 10 | Autolus Therapeutics | - | - | -1.04 Mn | 10.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 10.11 Mn |
| Dec 31, 2025 | 10.11 Mn |
| Sep 30, 2025 | 8.60 Mn |
| Sep 30, 2025 | 8.60 Mn |
| Jun 30, 2025 | 11.44 Mn |
| Jun 30, 2025 | 11.44 Mn |
| Mar 31, 2025 | 10.10 Mn |
| Mar 31, 2025 | 10.10 Mn |
| Dec 31, 2024 | 4.23 Mn |
| Dec 31, 2024 | 4.23 Mn |